Regulation of transgene expression in tumor cells by exploiting endogenous intracellular signals

Daisuke Asai, Jeong Hun Kang, Riki Toita, Akira Tsuchiya, Takuro Niidome, Hideki Nakashima, Yoshiki Katayama

研究成果: ジャーナルへの寄稿記事

3 引用 (Scopus)

抄録

Recently, we have proposed a novel strategy for a cell-specific gene therapy system based on responses to intracellular signals. In this system, an intracellular signal that is specifically and abnormally activated in the diseased cells is used for the activation of transgene expression. In this study, we used protein kinase C (PKC)α as a trigger to activate transgene expression. We prepared a PKCα-responsive polymer conjugate [PPC(S)] and a negative control conjugate [PPC(A)], in which the phosphorylation site serine (Ser) was replaced with alanine (Ala). The phosphorylation for polymer/DNA complexes was determined with a radiolabel assay using [γ- 32P]ATP. PPC(S)/DNA complexes were phosphorylated by the addition of PKCα, but no phosphorylation of the PPC(A)/DNA complex was observed. Moreover, after microinjection of polymer/GFP-encoding DNA complexes into HepG2 cells at cation/anion (C/A) ratios of 0.5 to 2.0, significant expression of GFP was observed in all cases using PPC(S)/DNA complexes, but no GFP expression was observed in the negative control PPC(A)/DNA complex-microinjected cells at C/A ratios of 1.0 and 2.0. On the other hand, GFP expression from PPC(S)/DNA complexes was completely suppressed in cells pretreated with PKCα inhibitor (Ro31-7549). These results suggest that our gene regulation system can be used for tumor cell-specific expression of a transgene in response to PKCα activity.

元の言語英語
ページ(範囲)229-233
ページ数5
ジャーナルNanoscale Research Letters
4
発行部数3
DOI
出版物ステータス出版済み - 3 1 2009

Fingerprint

Tumors
DNA
tumors
deoxyribonucleic acid
Cells
Protein Kinase C
phosphorylation
Phosphorylation
proteins
Proteins
cells
Polymers
Anions
Cations
polymers
Negative ions
Positive ions
gene therapy
anions
cations

All Science Journal Classification (ASJC) codes

  • Materials Science(all)
  • Condensed Matter Physics

これを引用

Regulation of transgene expression in tumor cells by exploiting endogenous intracellular signals. / Asai, Daisuke; Kang, Jeong Hun; Toita, Riki; Tsuchiya, Akira; Niidome, Takuro; Nakashima, Hideki; Katayama, Yoshiki.

:: Nanoscale Research Letters, 巻 4, 番号 3, 01.03.2009, p. 229-233.

研究成果: ジャーナルへの寄稿記事

Asai, Daisuke ; Kang, Jeong Hun ; Toita, Riki ; Tsuchiya, Akira ; Niidome, Takuro ; Nakashima, Hideki ; Katayama, Yoshiki. / Regulation of transgene expression in tumor cells by exploiting endogenous intracellular signals. :: Nanoscale Research Letters. 2009 ; 巻 4, 番号 3. pp. 229-233.
@article{a81b05d3a4644aae9e7ef3e86f0c632b,
title = "Regulation of transgene expression in tumor cells by exploiting endogenous intracellular signals",
abstract = "Recently, we have proposed a novel strategy for a cell-specific gene therapy system based on responses to intracellular signals. In this system, an intracellular signal that is specifically and abnormally activated in the diseased cells is used for the activation of transgene expression. In this study, we used protein kinase C (PKC)α as a trigger to activate transgene expression. We prepared a PKCα-responsive polymer conjugate [PPC(S)] and a negative control conjugate [PPC(A)], in which the phosphorylation site serine (Ser) was replaced with alanine (Ala). The phosphorylation for polymer/DNA complexes was determined with a radiolabel assay using [γ- 32P]ATP. PPC(S)/DNA complexes were phosphorylated by the addition of PKCα, but no phosphorylation of the PPC(A)/DNA complex was observed. Moreover, after microinjection of polymer/GFP-encoding DNA complexes into HepG2 cells at cation/anion (C/A) ratios of 0.5 to 2.0, significant expression of GFP was observed in all cases using PPC(S)/DNA complexes, but no GFP expression was observed in the negative control PPC(A)/DNA complex-microinjected cells at C/A ratios of 1.0 and 2.0. On the other hand, GFP expression from PPC(S)/DNA complexes was completely suppressed in cells pretreated with PKCα inhibitor (Ro31-7549). These results suggest that our gene regulation system can be used for tumor cell-specific expression of a transgene in response to PKCα activity.",
author = "Daisuke Asai and Kang, {Jeong Hun} and Riki Toita and Akira Tsuchiya and Takuro Niidome and Hideki Nakashima and Yoshiki Katayama",
year = "2009",
month = "3",
day = "1",
doi = "10.1007/s11671-008-9230-5",
language = "English",
volume = "4",
pages = "229--233",
journal = "Nanoscale Research Letters",
issn = "1931-7573",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Regulation of transgene expression in tumor cells by exploiting endogenous intracellular signals

AU - Asai, Daisuke

AU - Kang, Jeong Hun

AU - Toita, Riki

AU - Tsuchiya, Akira

AU - Niidome, Takuro

AU - Nakashima, Hideki

AU - Katayama, Yoshiki

PY - 2009/3/1

Y1 - 2009/3/1

N2 - Recently, we have proposed a novel strategy for a cell-specific gene therapy system based on responses to intracellular signals. In this system, an intracellular signal that is specifically and abnormally activated in the diseased cells is used for the activation of transgene expression. In this study, we used protein kinase C (PKC)α as a trigger to activate transgene expression. We prepared a PKCα-responsive polymer conjugate [PPC(S)] and a negative control conjugate [PPC(A)], in which the phosphorylation site serine (Ser) was replaced with alanine (Ala). The phosphorylation for polymer/DNA complexes was determined with a radiolabel assay using [γ- 32P]ATP. PPC(S)/DNA complexes were phosphorylated by the addition of PKCα, but no phosphorylation of the PPC(A)/DNA complex was observed. Moreover, after microinjection of polymer/GFP-encoding DNA complexes into HepG2 cells at cation/anion (C/A) ratios of 0.5 to 2.0, significant expression of GFP was observed in all cases using PPC(S)/DNA complexes, but no GFP expression was observed in the negative control PPC(A)/DNA complex-microinjected cells at C/A ratios of 1.0 and 2.0. On the other hand, GFP expression from PPC(S)/DNA complexes was completely suppressed in cells pretreated with PKCα inhibitor (Ro31-7549). These results suggest that our gene regulation system can be used for tumor cell-specific expression of a transgene in response to PKCα activity.

AB - Recently, we have proposed a novel strategy for a cell-specific gene therapy system based on responses to intracellular signals. In this system, an intracellular signal that is specifically and abnormally activated in the diseased cells is used for the activation of transgene expression. In this study, we used protein kinase C (PKC)α as a trigger to activate transgene expression. We prepared a PKCα-responsive polymer conjugate [PPC(S)] and a negative control conjugate [PPC(A)], in which the phosphorylation site serine (Ser) was replaced with alanine (Ala). The phosphorylation for polymer/DNA complexes was determined with a radiolabel assay using [γ- 32P]ATP. PPC(S)/DNA complexes were phosphorylated by the addition of PKCα, but no phosphorylation of the PPC(A)/DNA complex was observed. Moreover, after microinjection of polymer/GFP-encoding DNA complexes into HepG2 cells at cation/anion (C/A) ratios of 0.5 to 2.0, significant expression of GFP was observed in all cases using PPC(S)/DNA complexes, but no GFP expression was observed in the negative control PPC(A)/DNA complex-microinjected cells at C/A ratios of 1.0 and 2.0. On the other hand, GFP expression from PPC(S)/DNA complexes was completely suppressed in cells pretreated with PKCα inhibitor (Ro31-7549). These results suggest that our gene regulation system can be used for tumor cell-specific expression of a transgene in response to PKCα activity.

UR - http://www.scopus.com/inward/record.url?scp=59949097583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59949097583&partnerID=8YFLogxK

U2 - 10.1007/s11671-008-9230-5

DO - 10.1007/s11671-008-9230-5

M3 - Article

AN - SCOPUS:59949097583

VL - 4

SP - 229

EP - 233

JO - Nanoscale Research Letters

JF - Nanoscale Research Letters

SN - 1931-7573

IS - 3

ER -